Christopher D. Conrady
No Rating Available
(Learn About Our Rating System)

Christopher D. Conrady, MD, PhD

Languages spoken: English

Clinical Locations

Primary Location

John A. Moran Eye Center

65 N Mario Capecchi
Salt Lake City , UT 84132
801-581-2352
Get Directions

  • Christopher Conrady, MD, PhD

    Dr. Conrady is a clinician-researcher specializing in the diagnosis and treatment of uveitis and other infectious and inflammatory eye diseases. He also provides medical and surgical treatment of retinal diseases, including retinal detachments, age-related macular degeneration, diabetic retinopathy, and dislocated intraocular lenses.

    He is accepting new patients at the Moran Eye Center’s university location.

    Dr. Conrady earned his medical degree from the University of Oklahoma Health Sciences Center and completed a residency at the University of Utah School of Medicine and John A. Moran Eye Center.

    He completed a uveitis fellowship at the Moran Eye Center before heading to the University of Michigan Kellogg Eye Center for a surgical retina fellowship. These fellowships included training in repairing retinal detachments and dislocated lenses and the medical and surgical management of intraocular infections and lymphoma.

    He previously held a clinical and research faculty appointment at the University of Nebraska Medical Center (UNMC) Department of Ophthalmology and Visual Sciences. For his research pursuits, he earned a new investigator award and a physician-scientist award and was elected to the Council of Vision Editors fellowship and the prestigious Retina Society. He has served as a site principal investigator or sub-investigator on multiple clinical trials.

    At the University of Utah, he will also serve as principal investigator for a laboratory studying inflammatory eye diseases, such as acute retinal necrosis, a blinding herpes virus infection of the retina. His research interests include understanding the underlying genetic predisposition and early immune responses to viral infections of the retina to identify therapeutic targets and improve visual outcomes of acute retinal necrosis. He is also interested in advancing diagnostics and treatment protocols for endophthalmitis and other diseases characterized by intraocular inflammation.

    He has published more than 60 peer-reviewed journal articles and served as a reviewer for multiple scientific journals. He currently serves as a Basic and Clinical Science Course writer for the American Academy of Ophthalmology.

    Specialties

    Board Certification

    American Board of Ophthalmology

  • Dr. Conrady is a clinician-researcher specializing in the diagnosis and treatment of uveitis and other infectious and inflammatory eye diseases. He also provides medical and surgical treatment of retinal diseases, including retinal detachments, age-related macular degeneration, diabetic retinopathy, and dislocated intraocular lenses.

    He is accepting new patients at the Moran Eye Center’s university location.

    Dr. Conrady earned his medical degree from the University of Oklahoma Health Sciences Center and completed a residency at the University of Utah School of Medicine and John A. Moran Eye Center.

    He completed a uveitis fellowship at the Moran Eye Center before heading to the University of Michigan Kellogg Eye Center for a surgical retina fellowship. These fellowships included training in repairing retinal detachments and dislocated lenses and the medical and surgical management of intraocular infections and lymphoma.

    He previously held a clinical and research faculty appointment at the University of Nebraska Medical Center (UNMC) Department of Ophthalmology and Visual Sciences. For his research pursuits, he earned a new investigator award and a physician-scientist award and was elected to the Council of Vision Editors fellowship and the prestigious Retina Society. He has served as a site principal investigator or sub-investigator on multiple clinical trials.

    At the University of Utah, he will also serve as principal investigator for a laboratory studying inflammatory eye diseases, such as acute retinal necrosis, a blinding herpes virus infection of the retina. His research interests include understanding the underlying genetic predisposition and early immune responses to viral infections of the retina to identify therapeutic targets and improve visual outcomes of acute retinal necrosis. He is also interested in advancing diagnostics and treatment protocols for endophthalmitis and other diseases characterized by intraocular inflammation.

    He has published more than 60 peer-reviewed journal articles and served as a reviewer for multiple scientific journals. He currently serves as a Basic and Clinical Science Course writer for the American Academy of Ophthalmology.

    Board Certification and Academic Information

    Academic Departments Ophthalmology & Visual Sciences -Associate Professor
    Pathology -Adjunct Associate Professor
    Board Certification
    American Board of Ophthalmology

    Education history

    Undergraduate B.S. Biology; B.A. Spanish; Minor in Chemistry - Oklahoma City University B.S., B.A.
    Doctoral Training Microbiology and Immunology - University of Oklahoma Health Sciences Center Ph.D.
    Professional Medical Medicine - University of Oklahoma Health Sciences Center M.D.
    Internship Internal Medicine/Ophthalmology - University of Utah School of Medicine Intern
    Residency Ophthalmology - University of Utah School of Medicine Resident
    Fellowship Uveitis - University of Utah School of Medicine Fellow
    Fellowship Surgical Retina - University of Michigan Kellogg Eye Center Fellow

    Selected Publications

    Journal Article

    1. Bruening W, Kim S, Yeh S, Rishi P, Conrady C (2025). Inflammation and Occlusive Retinal Vasculitis Post Faricimab. JAMA ophthalmology, 143(3), 232-235. (Read full publication)
    2. Nguyen NV, Linderman SL, Fashina T, Devine M, Conrady CD, Shantha JG, Ahmed R, Yeh (2024). Case Reports: Chemokine and Cytokine Profiling in Patients with Herpetic Uveitis. International medical case reports journal, 17, 1055-1061. (Read full publication)
    3. Nguyen NV, Khan F, Cannon A, Huang Y, Kim L, Xu R, Rishi P, Conrady CD, Greiner TC, Yuil-Valdes A, Yeh (2024). Diagnosis of primary vitreoretinal lymphoma masquerading infectious retinitis by retinal biopsy. Journal of ophthalmic inflammation and infection, 14(1), 8. (Read full publication)
    4. Huang Y, Khan F, Chang M, Conrady CD, Yeh (2023). Utility of a nitinol stone extractor for intraocular foreign body removal. American journal of ophthalmology case reports, 32, 101917. (Read full publication)
    5. Menke BA, Wagner W, Song H, Thomas W, Almeida NEC, Conrady CD, Yeh (2024). Case report: CMV retinitis following local and systemic immunosuppression. Frontiers in ophthalmology, 4, 1354104. (Read full publication)
    6. Haliyur R, Sinha AK, Andrews CA, Musch DC, Conrady CD, Zacks DN, Huvard M (2024). NO EFFECT OF REAL-WORLD UNIVERSAL FACE MASKING ON POST-INTRAVITREAL INJECTION ENDOPHTHALMITIS RATE AT A SINGLE TERTIARY ACADEMIC CENTER. Retina (Philadelphia, Pa.), 44(5), 916-922. (Read full publication)
    7. Azeem A, Baartman B, Conrady CD, Meier JL, El-Herte (2023). Herpes simplex virus dissemination with necrotizing hepatitis following Descemet membrane endothelial keratoplasty. BMC infectious diseases, 23(1), 465. (Read full publication)
    8. Khan F, Conrady C (2024). A Case of Persistent Macular Edema and a Disappearing Tattoo. Ocular immunology and inflammation, 32(1), 123-126. (Read full publication)
    9. Fan S, Yoo JH, Park G, Yeh S, Conrady C (2022). Type I Interferon Signaling Is Critical During the Innate Immune Response to HSV-1 Retinal Infection. Investigative ophthalmology & visual science, 63(13), 28. (Read full publication)
    10. Conrady CD, Pradeep T, Yu Y, Johnson MW, VanderBeek B (2023). Association of Proton Pump Inhibitor/Histamine-2 Blocker Use and Ocular Toxoplasmosis: Findings from a Large US National Database. Ophthalmology. Retina, 7(3), 261-265. (Read full publication)
    11. Durrani AF, Jayasundera KT, Conrady C (2022). Diagnostic Dilemmas With a Great Ocular Masquerader. JAMA ophthalmology, 140(4), 432-433. (Read full publication)
    12. Conrady CD, Young BK, Besirli (2022). Worsening Angle Closure After Successful Laser Peripheral Iridotomy. JAMA ophthalmology, 140(4), 430-431. (Read full publication)
    13. Sassalos TM, Vitale AT, Conrady C (2021). Posterior scleritis and acute posterior multifocal placoid pigment epitheliopathy: A case of painful chorioretinitis and review of the current literature. American journal of ophthalmology case reports, 23, 101159. (Read full publication)
    14. Kutluturk I, Agarwal A, Shulman S, Vitale A, Parodi MB, Conrady CD, Hurtikova K, Cunha Souza E, Rodriguez EC, Chhablani J, Tappeiner C, Gerding H, Zinkernagel MS, Tucker W, Munk M (2021). The Clinical Characteristics of Unilateral Placoid Pigment Epitheliopathies. Ocular immunology and inflammation, 29(6), 1072-1079. (Read full publication)
    15. Hu KS, Vitale AT, Shakoor A, Larochelle M, Sassalos T, Elner SG, Jayasundera T, Conrady C (2022). Pyramidal Inflammatory Deposits of the Retinal Pigment Epithelium and Outer Retina in Ocular Syphilis. Ophthalmology. Retina, 6(2), 172-178. (Read full publication)
    16. Conrady CD, Demirci H, Wubben T (2020). Retinal Whitening After Lung Transplant for Cystic Fibrosis. JAMA ophthalmology, 138(9), 994-995. (Read full publication)
    17. Conrady CD, Sassalos T, Cornblath WT, Zacks DN, Johnson M (2021). Temporally independent association of multiple evanescent white dot syndrome and optic neuritis. Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie, 259(9), 2807-2811. (Read full publication)
    18. Conrady CD, Faia LJ, Gregg KS, Rao R (2021). Coronavirus-19-Associated Retinopathy. Ocular immunology and inflammation, 29(4), 675-676. (Read full publication)
    19. Conrady CD, Besirli CG, Baumal CR, Kovach JL, Etzel JD, Tsui JC, Elner SG, Johnson M (2022). Ocular Toxoplasmosis after Exposure to Wild Game. Ocular immunology and inflammation, 30(3), 527-532. (Read full publication)
    20. Rosenbaum JT, Harrington CA, Searles RP, Fei SS, Zaki A, Arepalli S, Paley MA, Hassman LM, Vitale AT, Conrady CD, Keath P, Mitchell C, Watson L, Planck SR, Martin TM, Choi (2021). Revising the Diagnosis of Idiopathic Uveitis by Peripheral Blood Transcriptomics. American journal of ophthalmology, 222, 15-23. (Read full publication)
    21. Rosenbaum JT, Harrington CA, Searles RP, Fei SS, Zaki A, Arepalli S, Paley MA, Hassman LM, Vitale AT, Conrady CD, Keath P, Mitchell C, Watson L, Planck SR, Martin TM, Choi (2021). Identifying RNA Biomarkers and Molecular Pathways Involved in Multiple Subtypes of Uveitis. American journal of ophthalmology, 226, 226-234. (Read full publication)
    22. Conrady CD, Shakoor A, Patel R, Larochelle M, Moshirfar M, Chaya CJ, Jacoby R, Vitale A (2020). Combined Phacoemulsification and Pars Plana Vitrectomy for the Treatment of Cataract in Patients With Noninfectious Uveitis. Journal of vitreoretinal diseases, 4(5), 393-400. (Read full publication)
    23. Conrady CD, Feist RM Jr, Vitale AT, Shakoor (2020). Long-term visual outcomes of endophthalmitis and the role of systemic steroids in addition to intravitreal dexamethasone. BMC ophthalmology, 20(1), 181. (Read full publication)
    24. Conrady CD, Feist RM Jr, Crum (2016). Shingles as the underlying cause of orbital myositis in an adolescent: A case report. American journal of ophthalmology case reports, 5, 111-113. (Read full publication)
    25. Khandwala NS, Miller JML, Hyde RA, Conrady CD, Rao RC, Besirli C (2021). The Diagnostic Conundrum of Retinitis and a Pigmented Scar. Case reports in ophthalmology, 12(1), 164-168. (Read full publication)

    Review

    1. Nguyen NM, Conrady C (2024). A Better Understanding of the Clinical and Pathological Changes in Viral Retinitis: Steps to Improve Visual Outcomes. Microorganisms, 12(12), (Read full publication)
    2. Blyden K, Thomas J, Emami-Naeini P, Fashina T, Conrady CD, Albini TA, Carag J, Yeh (2024). Emerging Infectious Diseases and the Eye: Ophthalmic Manifestations, Pathogenesis, and One Health Perspectives. International ophthalmology clinics, 64(4), 39-54. (Read full publication)
    3. Harrison-Williams L, Vandy MJ, Mattia JG, Hartley CD, Fashina T, Huang Y, Choo C, Yeh C, Huang C, Nguyen N, Conteh I, Campbell K, Konneh A, Hayek BR, Shantha JG, Crozier I, Mwanza JC, Conrady CD, Justin GA, Yeh S, Mustapha J, SMILE and EVICT-VR Study Investigator (2024). Establishing Vitreoretinal Surgery Capacity in Sierra Leone: Challenges and Opportunities to Address Retinal Health Disparities in Resource-limited Settings. International ophthalmology clinics, 64(4), 31-38. (Read full publication)
    4. Ohlhausen M, Menke BA, Begley J, Kim S, Debiec MR, Conrady CD, Yeh S, Justin G (2024). Advances in the management of intraocular foreign bodies. Frontiers in ophthalmology, 4, 1422466. (Read full publication)
    5. Curran EH, Devine MD, Hartley CD, Huang Y, Conrady CD, Debiec MR, Justin GA, Thomas J, Yeh (2024). Ophthalmic implications of biological threat agents according to the chemical, biological, radiological, nuclear, and explosives framework. Frontiers in medicine, 10, 1349571. (Read full publication)
    6. Dempsey MP, Conrady C (2023). The Host-Pathogen Interplay: A Tale of Two Stories within the Cornea and Posterior Segment. Microorganisms, 11(8), (Read full publication)
    7. Arunkumar R, Calvo CM, Conrady CD, Bernstein P (2018). What do we know about the macular pigment in AMD: the past, the present, and the future. Eye (London, England), 32(5), 992-1004. (Read full publication)
    8. Fashina T, Huang Y, Thomas J, Conrady CD, Yeh (2022). Ophthalmic Features and Implications of Poxviruses: Lessons from Clinical and Basic Research. Microorganisms, 10(12), (Read full publication)
    9. Conrady CD, Yeh (2021). A Review of Ocular Drug Delivery Platforms and Drugs for Infectious and Noninfectious Uveitis: The Past, Present, and Future. Pharmaceutics, 13(8), (Read full publication)
    10. Conrady CD, Shakoor (2020). Rituximab-Associated Retinal Occlusive Vasculopathy: A Case Report and Literature Review. Ocular immunology and inflammation, 28(4), 622-625. (Read full publication)
    11. Feng Y, Conrady CD, Demirci (2021). The evolution of an active solitary idiopathic choroiditis (focal scleral nodule): a case report of the natural course and a review of the literature. BMC ophthalmology, 21(1), 130. (Read full publication)

    Editorial

    1. Conrady C (2023). Infectious Eye Diseases and Prevention Control. Microorganisms, 11(5), (Read full publication)